China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.1400
0.00 (0.00%)
Apr 11, 2025, 4:00 PM EDT - Market closed

China Pharma Holdings Revenue

In the year 2024, China Pharma Holdings had annual revenue of $4.53M, down -35.41%. China Pharma Holdings had revenue of $1.13M in the quarter ending December 31, 2024, a decrease of -47.25%.

Revenue (ttm)
$4.53M
Revenue Growth
-35.41%
P/S Ratio
0.54
Revenue / Employee
$19,606
Employees
231
Market Cap
4.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.53M-2.48M-35.41%
Dec 31, 20237.01M-1.09M-13.48%
Dec 31, 20228.10M-1.54M-15.95%
Dec 31, 20219.64M-1.22M-11.27%
Dec 31, 202010.87M-57.49K-0.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
McKesson 344.58B
HCA Healthcare 70.60B
AstraZeneca 54.07B
Novartis AG 51.72B
Sanofi 45.85B
Thermo Fisher Scientific 42.88B
GSK plc 39.28B
Medtronic 33.20B
Revenue Rankings